RxDoctor Payments DataLook up a doctor →

Frank Bowden, MD

Ophthalmology · Jacksonville, FLNPI 1952302523

Payments from drug & device makers

$373,832in general payments, 2019–2025

Across 649 payments — averaging $576.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$89K
  • AbbVie$74K
  • Sun Pharmaceutical Industries Inc.$55K
  • Shire North American Group Inc$48K
  • Novartis$39K
  • Johnson & Johnson Vision Care, Inc.$28K
  • plus $40K from 30 others
$6,702in research payments, 2019–2025

Across 1 payment — averaging $6702.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$7K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$373,832 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida

Medicare billing

Part B allowed, 2024
$405,104
Medicare patients
529
Services billed
6,761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →